Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lu

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Disease Models & Mechanisms|June 20, 2018
Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetesBrian Lu, Kiran Kurmi, Miguel Munoz-Gomez, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 10, 2019
Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) QuestionnaireWesley Y Yu, Rick Waalboer-Spuij, Rebecca Bremer, et al.
Frontiers in Oncology|September 23, 2021
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Frontiers in Oncology|June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
JAMA Dermatology|December 5, 2019
Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical TrialWesley Y Yu, Brian Lu, Daniel Tan, et al.
Nanoscale|April 7, 2026
Polyethersulfone films as promising biomaterials for reducing granuloma formation and preserving tissue compatibilityAndrew E-Y Chuang, Chia-Hung Liu, Brian Lu, et al.
Frontiers in Immunology|October 3, 2024
Differential lipid signaling from CD4<sup>+</sup> and CD8<sup>+</sup> T cells contributes to type 1 diabetes developmentTayleur D White, Abdulaziz Almutairi, Ying Gai-Tusing, et al.
Annals of Surgical Oncology|April 4, 2021
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic AdenocarcinomaMichele Reni, Julia Braverman, Andrew Hendifar, et al.
Journal of Neurosurgery|October 8, 2022
Predictors of surgical site infection in glioblastoma patients undergoing craniotomy for tumor resectionSumil K Nair, David Botros, Sachiv Chakravarti, et al.
BMC Cancer|December 24, 2017
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyRuihua Xu, Xianjun Yu, Jihui Hao, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Disease Models & Mechanisms|June 20, 2018
Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetesBrian Lu, Kiran Kurmi, Miguel Munoz-Gomez, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 10, 2019
Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) QuestionnaireWesley Y Yu, Rick Waalboer-Spuij, Rebecca Bremer, et al.
Frontiers in Oncology|September 23, 2021
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Frontiers in Oncology|June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
JAMA Dermatology|December 5, 2019
Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical TrialWesley Y Yu, Brian Lu, Daniel Tan, et al.
Nanoscale|April 7, 2026
Polyethersulfone films as promising biomaterials for reducing granuloma formation and preserving tissue compatibilityAndrew E-Y Chuang, Chia-Hung Liu, Brian Lu, et al.
Frontiers in Immunology|October 3, 2024
Differential lipid signaling from CD4<sup>+</sup> and CD8<sup>+</sup> T cells contributes to type 1 diabetes developmentTayleur D White, Abdulaziz Almutairi, Ying Gai-Tusing, et al.
Annals of Surgical Oncology|April 4, 2021
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic AdenocarcinomaMichele Reni, Julia Braverman, Andrew Hendifar, et al.
Journal of Neurosurgery|October 8, 2022
Predictors of surgical site infection in glioblastoma patients undergoing craniotomy for tumor resectionSumil K Nair, David Botros, Sachiv Chakravarti, et al.
BMC Cancer|December 24, 2017
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyRuihua Xu, Xianjun Yu, Jihui Hao, et al.
Pageof 5